Skip to main content
SpringerLink
Log in
Book cover

Comprehensive Geriatric Assessment pp 69–77Cite as

Comprehensive Geriatric Assessment and Personalized Medicine

  • Chapter
  • First Online:

Part of the book series: Practical Issues in Geriatrics ((PIG))

Abstract

There is increasing evidence that personalized medicine, an evolving field where patient management is based on individual genetic, molecular or cellular characteristics, improves the outcome of several disease states, particularly cancer. However, the routine application of personalized medicine in the ever-growing cohort of frail older patients presents significant challenges because of the confounding impact of coexisting disease states, polypharmacy, and interindividual variability in homeostatic capacity and treatment response. Furthermore, the use of conventional, disease-specific, end points, typically investigated in clinical trials conducted in younger and/or healthier subjects, is also questionable in patients with poor functional status and limited life expectancy. In this patient group, the maintenance of independence is key to self-rated health. However, whether measures of independence and quality of life can be used to better select treatment strategies and improve outcomes in older patients remains to be investigated. The development of robust and validated tools to quantify key components of the comprehensive geriatric assessment provides opportunities to (a) design interventions that take into account measures of frailty and functional status and (b) investigate the role of patient-centred end points in monitoring the effects of such interventions. In this context, an age-adapted definition, patient-centred medicine, indicates a management approach primarily based on measures of frailty and quality of life, rather than more fundamental genetic or molecular factors. Research is warranted to investigate whether combining personalized medicine with patient-centred medicine leads to more effective and safe management strategies in old age.

This is a preview of subscription content, log in via an institution.

References

  1. Mavaddat N, Antoniou AC, Easton DF, Garcia-Closas M (2010) Genetic susceptibility to breast cancer. Mol Oncol 4(3):174–191. doi:10.1016/j.molonc.2010.04.011

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  2. Sabatine MS, Liu E, Morrow DA, Heller E, McCarroll R, Wiegand R et al (2005) Metabolomic identification of novel biomarkers of myocardial ischemia. Circulation 112(25):3868–3875. doi:10.1161/CIRCULATIONAHA.105.569137

    Article  CAS  PubMed  Google Scholar 

  3. Newell KA, Asare A, Kirk AD, Gisler TD, Bourcier K, Suthanthiran M et al (2010) Identification of a B cell signature associated with renal transplant tolerance in humans. J Clin Invest 120(6):1836–1847. doi:10.1172/JCI39933

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  4. International Warfarin Pharmacogenetics Consortium, Klein TE, Altman RB, Eriksson N, Gage BF, Kimmel SE et al (2009) Estimation of the warfarin dose with clinical and pharmacogenetic data. N Engl J Med 360(8):753–764. doi:10.1056/NEJMoa0809329

    Article  Google Scholar 

  5. Fabbri E, Zoli M, Gonzalez-Freire M, Salive ME, Studenski SA, Ferrucci L (2015) Aging and multimorbidity: new tasks, priorities, and frontiers for integrated gerontological and clinical research. J Am Med Dir Assoc 16(8):640–647. doi:10.1016/j.jamda.2015.03.013

    Article  PubMed  PubMed Central  Google Scholar 

  6. Sostres C, Gargallo CJ, Lanas A (2013) Nonsteroidal anti-inflammatory drugs and upper and lower gastrointestinal mucosal damage. Arthritis Res Ther 15(Suppl 3):S3. doi:10.1186/ar4175

    Article  PubMed  PubMed Central  Google Scholar 

  7. Singh BK, Haque SE, Pillai KK (2014) Assessment of nonsteroidal anti-inflammatory drug-induced cardiotoxicity. Expert Opin Drug Metab Toxicol 10(2):143–156. doi:10.1517/17425255.2014.856881

    Article  CAS  PubMed  Google Scholar 

  8. Mangoni AA, Woodman RJ, Gaganis P, Gilbert AL, Knights KM (2010) Use of non-steroidal anti-inflammatory drugs and risk of incident myocardial infarction and heart failure, and all-cause mortality in the Australian veteran community. Br J Clin Pharmacol 69(6):689–700. doi:10.1111/j.1365-2125.2010.03627.x

    Article  PubMed  PubMed Central  Google Scholar 

  9. Moore N, Pollack C, Butkerait P (2015) Adverse drug reactions and drug-drug interactions with over-the-counter NSAIDs. Ther Clin Risk Manag 11:1061–1075. doi:10.2147/TCRM.S79135

    CAS  PubMed  PubMed Central  Google Scholar 

  10. Chan IS, Ginsburg GS (2011) Personalized medicine: progress and promise. Annu Rev Genomics Hum Genet 12:217–244. doi:10.1146/annurev-genom-082410-101446

    Article  CAS  PubMed  Google Scholar 

  11. Ma ZS, Abdo Z, Forney LJ (2011) Caring about trees in the forest: incorporating frailty in risk analysis for personalized medicine. Per Med 8(6):681–688. doi:10.2217/pme.11.72

    Article  PubMed  Google Scholar 

  12. Quine S, Morrell S (2007) Fear of loss of independence and nursing home admission in older Australians. Health Soc Care Community 15(3):212–220. doi:10.1111/j.1365-2524.2006.00675.x

    Article  PubMed  Google Scholar 

  13. Mangoni AA, Pilotto A (2016) New drugs and patient-centred end-points in old age: setting the wheels in motion. Expert Rev Clin Pharmacol 9(1):81–89. doi:10.1586/17512433.2016.1100074

    Article  CAS  PubMed  Google Scholar 

  14. Lowry E, Woodman RJ, Soiza RL, Hilmer SN, Mangoni AA (2012) Drug burden index, physical function, and adverse outcomes in older hospitalized patients. J Clin Pharmacol 52(10):1584–1591. doi:10.1177/0091270011421489

    Article  PubMed  Google Scholar 

  15. Lowry E, Woodman RJ, Soiza RL, Mangoni AA (2011) Associations between the anticholinergic risk scale score and physical function: potential implications for adverse outcomes in older hospitalized patients. J Am Med Dir Assoc 12(8):565–572. doi:10.1016/j.jamda.2011.03.006

    Article  PubMed  Google Scholar 

  16. Ruxton K, Woodman RJ, Mangoni AA (2015) Drugs with anticholinergic effects and cognitive impairment, falls and all-cause mortality in older adults: a systematic review and meta-analysis. Br J Clin Pharmacol 80(2):209–220. doi:10.1111/bcp.12617

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  17. Mangoni AA (2012) Predicting and detecting adverse drug reactions in old age: challenges and opportunities. Expert Opin Drug Metab Toxicol 8(5):527–530. doi:10.1517/17425255.2012.665874

    Article  CAS  PubMed  Google Scholar 

  18. Mangoni AA, Jansen PA, Jackson SH (2013) Under-representation of older adults in pharmacokinetic and pharmacodynamic studies: a solvable problem? Expert Rev Clin Pharmacol 6(1):35–39. doi:10.1586/ecp.12.75

    Article  CAS  PubMed  Google Scholar 

  19. Mangoni AA, Jackson SH (2004) Age-related changes in pharmacokinetics and pharmacodynamics: basic principles and practical applications. Br J Clin Pharmacol 57(1):6–14

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  20. Reeve E, Wiese MD, Mangoni AA (2015) Alterations in drug disposition in older adults. Expert Opin Drug Metab Toxicol 11(4):491–508. doi:10.1517/17425255.2015.1004310

    Article  PubMed  Google Scholar 

  21. Jackson SH, Jansen PA, Mangoni AA (2012) Off-label prescribing in older patients. Drugs Aging 29(6):427–434. doi:10.2165/11633520-000000000-00000

    Article  CAS  PubMed  Google Scholar 

  22. Tinetti ME, McAvay GJ, Chang SS, Newman AB, Fitzpatrick AL, Fried TR et al (2011) Contribution of multiple chronic conditions to universal health outcomes. J Am Geriatr Soc 59(9):1686–1691. doi:10.1111/j.1532-5415.2011.03573.x

    Article  PubMed  PubMed Central  Google Scholar 

  23. Wong CH, Weiss D, Sourial N, Karunananthan S, Quail JM, Wolfson C et al (2010) Frailty and its association with disability and comorbidity in a community-dwelling sample of seniors in Montreal: a cross-sectional study. Aging Clin Exp Res 22(1):54–62. doi:10.3275/6675

    Article  PubMed  Google Scholar 

  24. Stuck AE, Siu AL, Wieland GD, Adams J, Rubenstein LZ (1993) Comprehensive geriatric assessment: a meta-analysis of controlled trials. Lancet 342(8878):1032–1036

    Article  CAS  PubMed  Google Scholar 

  25. Rodriguez-Manas L, Fried LP (2015) Frailty in the clinical scenario. Lancet 385(9968):e7–e9. doi:10.1016/S0140-6736(14)61595-6

    Article  PubMed  Google Scholar 

  26. Deckx L, van den Akker M, Daniels L, De Jonge ET, Bulens P, Tjan-Heijnen VC et al (2015) Geriatric screening tools are of limited value to predict decline in functional status and quality of life: results of a cohort study. BMC Fam Pract 16:30. doi:10.1186/s12875-015-0241-x

    Article  PubMed  PubMed Central  Google Scholar 

  27. Pilotto A, Ferrucci L, Franceschi M, D'Ambrosio LP, Scarcelli C, Cascavilla L et al (2008) Development and validation of a multidimensional prognostic index for one-year mortality from comprehensive geriatric assessment in hospitalized older patients. Rejuvenation Res 11(1):151–161. doi:10.1089/rej.2007.0569

    Article  PubMed  PubMed Central  Google Scholar 

  28. Pilotto A, Rengo F, Marchionni N, Sancarlo D, Fontana A, Panza F et al (2012) Comparing the prognostic accuracy for all-cause mortality of frailty instruments: a multicentre 1-year follow-up in hospitalized older patients. PLoS One 7(1):e29090. doi:10.1371/journal.pone.0029090

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  29. D'Onofrio G, Sancarlo D, Addante F, Ciccone F, Cascavilla L, Paris F et al (2015) A pilot randomized controlled trial evaluating an integrated treatment of rivastigmine transdermal patch and cognitive stimulation in patients with Alzheimer's disease. Int J Geriatr Psychiatry 30(9):965–975. doi:10.1002/gps.4247

    Article  PubMed  Google Scholar 

  30. Pilotto A, D'Onofrio G, Panza F, Copetti M, Cascavilla L, Paris F et al (2012) Treatment of late-life major depressive disorder with selective serotonin reuptake inhibitors improves the multidimensional prognostic index. J Clin Psychopharmacol 32(5):726–729. doi:10.1097/JCP.0b013e31826866bd

    Article  PubMed  Google Scholar 

  31. Davidson PM, Newton PJ, Tankumpuan T, Paull G, Dennison-Himmelfarb C (2015) Multidisciplinary management of chronic heart failure: principles and future trends. Clin Ther 37(10):2225–2233. doi:10.1016/j.clinthera.2015.08.021

    Article  PubMed  Google Scholar 

  32. Wolfs CA, Kessels A, Dirksen CD, Severens JL, Verhey FR (2008) Integrated multidisciplinary diagnostic approach for dementia care: randomised controlled trial. Br J Psychiatry 192(4):300–305. doi:10.1192/bjp.bp.107.035204

    Article  PubMed  Google Scholar 

  33. Wilson PW, Pencina M, Jacques P, Selhub J, D'Agostino R Sr, O'Donnell CJ (2008) C-reactive protein and reclassification of cardiovascular risk in the Framingham heart study. Circ Cardiovasc Qual Outcomes 1(2):92–97. doi:10.1161/CIRCOUTCOMES.108.831198

    Article  PubMed  PubMed Central  Google Scholar 

  34. van Veldhuisen DJ, Linssen GC, Jaarsma T, van Gilst WH, Hoes AW, Tijssen JG et al (2013) B-type natriuretic peptide and prognosis in heart failure patients with preserved and reduced ejection fraction. J Am Coll Cardiol 61(14):1498–1506. doi:10.1016/j.jacc.2012.12.044

    Article  PubMed  Google Scholar 

  35. Ekerstad N, Swahn E, Janzon M, Alfredsson J, Lofmark R, Lindenberger M et al (2011) Frailty is independently associated with short-term outcomes for elderly patients with non-ST-segment elevation myocardial infarction. Circulation 124(22):2397–2404. doi:10.1161/CIRCULATIONAHA.111.025452

    Article  PubMed  Google Scholar 

  36. Vidan MT, Blaya-Novakova V, Sanchez E, Ortiz J, Serra-Rexach JA, Bueno H (2016) Prevalence and prognostic impact of frailty and its components in non-dependent elderly patients with heart failure. Eur J Heart Fail 18(7):869–875. doi:10.1002/ejhf.518

    Article  CAS  PubMed  Google Scholar 

  37. Soysal P, Stubbs B, Lucato P, Luchini C, Solmi M, Peluso R et al (2016) Inflammation and frailty in the elderly: a systematic review and meta-analysis. Ageing Res Rev 31:1–8. doi:10.1016/j.arr.2016.08.006

    Article  CAS  PubMed  Google Scholar 

  38. Nishiguchi S, Nozaki Y, Yamaji M, Oya K, Hikita Y, Aoyama T et al (2016) Plasma brain natriuretic peptide level in older outpatients with heart failure is associated with physical frailty, especially with the slowness domain. J Geriatr Cardiol 13(7):608–614. doi:10.11909/j.issn.1671-5411.2016.07.014

    PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Clinical Pharmacology, School of Medicine, Flinders University and Flinders Medical Centre, Bedford Park, Adelaide, SA, 5042, Australia

    Arduino A. Mangoni

Authors
  1. Arduino A. Mangoni
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Arduino A. Mangoni .

Editor information

Editors and Affiliations

  1. Geriatric Care, Orthogeriatrics and Rehab, Ospedali Galliera, Genoa, Italy

    Alberto Pilotto

  2. Dept. of Aging and Health, St. Thomas Hospital, London, United Kingdom

    Finbarr C. Martin

Rights and permissions

Reprints and permissions

Copyright information

© 2018 Springer International Publishing AG

About this chapter

Cite this chapter

Mangoni, A.A. (2018). Comprehensive Geriatric Assessment and Personalized Medicine. In: Pilotto, A., Martin, F. (eds) Comprehensive Geriatric Assessment. Practical Issues in Geriatrics. Springer, Cham. https://doi.org/10.1007/978-3-319-62503-4_7

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-62503-4_7

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-62502-7

  • Online ISBN: 978-3-319-62503-4

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation